McKesson Corporation

MCK

US58155Q1031

McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows: - distribution of pharmaceutical products (87%); - distribution of medical and surgical products (4%); - other (1.6%): primarily technology services and software sales. The remaining net sales (7.4%) are from international activities.

Employees

48,000

Sector

Pharmaceuticals

Calendar

2024-10-28 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

508.16USD

Average target price

612.53USD

Spread / Average Target

+20.54%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 04:00:02 2024-09-19 pm EDT			5-day change	1st Jan Change
508.16 ^USD	-0.68%		-0.59%	+9.76%

Sep. 19	Evercore ISI Adjusts Price Target on McKesson to $560 From $630, Maintains Outperform Rating	MT
Sep. 16	Central bank bonanza!

Evercore ISI Adjusts Price Target on McKesson to $560 From $630, Maintains Outperform Rating	Sep. 19	MT
Central bank bonanza!	Sep. 16
Deutsche Bank Trims Price Target on McKesson to $623 From $631	Sep. 13	MT
Wells Fargo Cuts McKesson's Price Target to $535 From $576, Equalweight Rating Maintained	Sep. 12	MT
Jefferies Adjusts Price Target on McKesson to $607 From $630	Sep. 10	MT
Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree...	Sep. 10
Citigroup Cuts Price Target on McKesson to $630 From $670	Sep. 10	MT
Baird Adjusts Price Target on McKesson to $603 From $671, Maintains Outperform Rating	Sep. 06	MT
Sector Update: Health Care Stocks Fall Late Afternoon	Sep. 05	MT
Sector Update: Health Care	Sep. 05	MT
Top Midday Decliners	Sep. 05	MT
Sector Update: Health Care Stocks Slide Thursday Afternoon	Sep. 05	MT
McKesson Shares Fall After Hinting Lower-Than-Expected Fiscal Q2 Earnings Outlook	Sep. 05	MT
US Equity Indexes Mixed as Investors Eye Friday's Nonfarm Payrolls After Private Jobs Unexpectedly Slow Down	Sep. 05	MT
Sector Update: Health Care	Sep. 05	MT
US Equity Indexes Mixed Following Surprise Deceleration in Private Jobs	Sep. 05	MT
Leerink Partners Adjusts McKesson Price Target to $665 From $670, Maintains Outperform Rating	Sep. 05	MT
McKesson Corporation Announces Unchanged Guidance for the Full Year 2024	Sep. 05	CI
McKesson Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-05-2024 08:45 AM	Sep. 05
McKesson to Sell Rexall, Well.ca Businesses to Birch Hill Equity Partners	Sep. 05	MT
Birch Hill Equity Partners Management Inc. signed an agreement to acquire Rexall and Well.ca businesses of McKesson Corporation.	Sep. 04	CI
Rite Aid Exits Chapter 11, Appoints New CEO, Clears $2 Billion in Debt	Sep. 03	MT
Drug distributors strike $300 million opioid settlement with US health plans	Aug. 30	RE
Atlanta Braves Holdings, Inc. Appoints Jill Robinson as Chief Financial Officer, Effective September 1, 2024	Aug. 29	CI
Sector Update: Health Care Stocks Ease	Aug. 26	MT

McKesson Corporation

Equities

MCK

US58155Q1031

Pharmaceuticals

Latest news about McKesson Corporation

Chart McKesson Corporation

Company Profile

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise